Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ALDARA
- Coadministration of GA2 Sporozoites With Adjuvants
- Topical Aldara (Imiquimod) for Oral Cancer
- A MultIceNTER Phase I Peptide VaCcine Trial for the Treatment of H3-Mutated Gliomas
- Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors
- Imiquimod for Preventing Keloid Recurrence
- A Study to Evaluate Neoadjuvant Sonidegib Followed by Surgery or Imiquimod in the Management of Basal Cell Carcinoma
- H5N1 With or Without Topical Aldara in Healthy Adults
- Intralesional 5-Fluorouracil (5FU), Topical Imiquimod Treatment for SCC
- Adjuvant Anal Imiquimod Therapy in Anal HPV-lesions: AdAM-trial
- Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma
- Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial Neoplasia
- Imiquimod and Influenza Vaccine for Immunocompromised Patients
- iVAC-CLL01: Patient-individualized Peptide Vaccination After First Line Therapy of CLL
- Safety, Tolerability, and Immunogenicity of GTL001 Vaccine Adjuvanted With Imiquimod Cream in HPV 16- and/or HPV 18-Infected Women Aged 25 to 65 Years, With Normal Cytology, ASCUS, or LSIL
- Imiquimod Treatment of Residual or Recurrent CIN Lesions: a Study Protocol
- Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer
- Efficacy and Tolerability of Topical LFX453 for External Genital Warts
- Radiotherapy or Imiquimod in Complex Lentigo Maligna
- Topical 5% Imiquimod Cream for Vulvar Paget's Disease
- IM Versus 5-FU Versus IMI Versus MAL-PDT in Treatment of Actinic Keratosis
- Surgery Versus Combined Treatment With Curettage and Imiquimod for Nodular Basal Cell Carcinoma
- Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions
- Topical Imiquimod vs. LEEP for Women With Carcinoma In-situ of the Cervix
- A Study to Evaluate the Safety and Efficacy Imiquimod Cream, 2.5% in Participants With Actinic Keratoses
- Intradermal Influenza Vaccine in the Young
- Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions
- Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer
- Primary Imiquimod Treatment Versus Surgery for Vulvar Intraepithelial Neoplasia
- Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma
- Dendritic Cell Vaccine for Children and Adults With Sarcoma
- Imiquimod and Tumor Lysate Vaccine Immunotherapy in Adults With High Risk or Recurrent Grade II Gliomas
- Anal Dysplasia Study of Men Who Have Sex With Men Living With HIV
- Identification of Novel Biomarkers of Cervicovaginal Mucosal Inflammation
- Intradermal Trivalent Influenza Vaccine With Imiquimod
- Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2)
- Toll-like Receptor (TLR) 7 Agonist, Cyclophosphamide, and Radiotherapy for Breast Cancer With Skin Metastases
- Oral Miltefosine Plus Topical Imiquimod to Treat Cutaneous Leishmaniasis
- Combination Therapy of Topical Imiquimod Plus Multipeptide Vaccination for Cutaneous Metastases of Melanoma
- Peptide Vaccination Associated With Tumoral Immunomodulation in Patients With Advanced Metastatic Melanoma
- Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor
- Imiquimod to Detect Residual Lesions and Prevent Recurrence of Lentigo Maligna
- Comparison of Five Treatments in Patients With Plantar Warts
- The Effects of Aldara as an Adjunct to Laser Treatment
- Bioequivalence of Generic Imiquimod Cream, 5% When Compared to Aldara™ (Imiquimod) Cream, 5% in the Treatment of Actinic Keratosis
- ITIC (Imiquimod Therapy in Cervical Intraepithelial Neoplasia)-Trial
- Imiquimod for Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases
- A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Therapeutic Equivalence Study of Three Imiquimod Cream 5% Treatments for Patients With Actinic Keratosis
- Treatment Study for Actinic Cheilitis Comparing Imiquimod 5% and Photodynamic Therapy
- Bioequivalence Study of Two Imiquimod Cream 5%
- Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast Cancer
- Imiquimod 5% Cream for the Treatment of Periocular Basal Cell Carcinoma
- Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses
- Topical Imiquimod Cream in Combination With Cryotherapy for the Treatment of Actinic Keratoses
- Topical Imiquimod in Conjunction With Nd:YAG Laser for Tattoo Removal
- Safety and Effectiveness Study of Imiquimod Creams for Treatment of Actinic Keratoses (AKs)
- Safety and Effectiveness Study of Imiquimod Creams for the Treatment of Actinic Keratoses (AKs)
- Mechanistically-based Optimization of UV Radiation Therapy in Psoriasis
- Pilot Study of Oral 852A for Elimination of High-Grade Dysplasia in Barrett's Esophagus
- Cellular and Molecular Events During Treatment of Actinic Keratosis With Imiquimod 5% Cream
- Evaluation of Two Different Non-Invasive Techniques to Monitor the Clearance of Actinic Keratosis Lesions
- Evaluation of the Impact of Adjuvants Accompanying Peptide Immunization in High-Risk Melanoma
- Imiquimod Plus Antimony Immunochemotherapy for Cutaneous Leishmaniasis
- Aldara for the Treatment of Large and/or Multiple sBCC
- Aldara for the Treatment of Extensive Alopecia Areata
- Characteristics of T Cells From Alopecia Areata Scalp Skin Before and After Treatment With Aldara 5%
- NY-ESO-1 Protein Vaccine With Imiquimod in Melanoma (Adjuvant Setting)
- Imiquimod Cream in Treating Patients With Basal Cell Skin Cancer
Clinical trials list
click for details